Screening and diagnosis of gestational diabetes
BMJ
.
2023 May 2:381:e071920.
doi: 10.1136/bmj-2022-071920.
Authors
S L White
1
2
,
G Ayman
3
,
C Bakhai
4
5
,
T A Hillier
6
7
,
L A Magee
8
Affiliations
1
Department of Women and Children's Health, King's College London, London SE1 7EH, UK sara.white@kcl.ac.uk.
2
Department of Diabetes and Endocrinology, Guy's and St Thomas' Hospitals NHS Foundation Trust, London, SE1 7EH, UK.
3
Nuffield Department of Population Health, University of Oxford, Headington, Oxford OX3 7LF, UK.
4
Larkside Practice, Luton LU2 9SB, UK.
5
Bedfordshire, Luton and Milton Keynes Integrated Care Board, Luton LU1 2LJ, UK.
6
Center for Health Research, Kaiser Permanente Northwest, Portland, OR 97227, USA.
7
Center for Integrated Health Care Research, Kaiser Permanente Hawaii, Honolulu, HI 96817, USA.
8
Department of Women and Children's Health, King's College London, London SE1 7EH, UK.
PMID:
37130610
DOI:
10.1136/bmj-2022-071920
No abstract available
MeSH terms
Diabetes, Gestational* / diagnosis
Female
Humans
Mass Screening
Pregnancy
Risk Factors